Good Documentation Practices - GOV.UK
•Records: Provide evidence of various actions taken to demonstrate compliance with instructions, e.g. activities, events, investigations, and in the case of manufactured batches a history
Download Good Documentation Practices - GOV.UK
Information
Domain:
Source:
Link to this page:
Documents from same domain
The Human Medicines Regulations 2012 – …
www.mhra.gov.ukThe Human Medicines Regulations 2012 – description of each Part This document provides a brief overview of each Part of the Human Medicines Regulations 2012 …
FULTIUM -D 800 IU CAPSULES - GOV.UK
www.mhra.gov.ukVitamin D deficiency, with levels of 25(OH)D below 25nmol/L (10ng/ml), could result in the disease rickets (or osteomalacia). The disease resulting as a deficiency is considered to be due to malabsorption
GLYCOPYRRONIUM BROMIDE 0.2MG/ML …
www.mhra.gov.ukUKPAR Glycopyrronium Bromide 0.2 mg/ml Solution for Injection PL 00156/0115 1 GLYCOPYRRONIUM BROMIDE 0.2MG/ML SOLUTION FOR INJECTION (PL 00156/0115)
Meloxicam - GOV.UK
www.mhra.gov.ukPL 31388/0003-4 UKPAR Alpex Pharma (UK) Ltd, Meloxicam 7.5mg and 15mg Orodispersible Tablets 3 Scientific Discussion INTRODUCTION Based on the review of the data on quality, safety and efficacy, the UK granted
PL 00010/0643 - GOV.UK
www.mhra.gov.ukUKPAR Canesten HC Cream PL 00010/0643 6 All excipients comply with their respective European Pharmacopoeia monographs, except triceteareth-4-
Public Assessment Report UKPAR Canesten Combi …
www.mhra.gov.ukThis is a summary of the Public Assessment Report (PAR) for Canesten Combi Pessary & External Cream 500mg / 2% w/w pessary & cream (PL 00010/0653).
DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 g ...
www.mhra.gov.ukPAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure
Public Assessment Report Mutual Recognition …
www.mhra.gov.ukPAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION
Cefixime 400 mg Film-coated Tablets, PL 22805 …
www.mhra.gov.ukMHRA PAR; CEFIXIME 400 MG FILM-COATED TABLETS, PL 22805/0032-3 2 Lay summary The Medicines and Healthcare products Regulatory Agency …
Public Assessment Report Decentralised Procedure …
www.mhra.gov.ukPublic Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC
Related documents
Annex 9 Guide to good storage practices for pharmaceuticals
apps.who.int126 • The cold chain, especially for vaccines and biologicals; • The International Pharmacopoeia (4). The objective of this guide is to supplement the above-mentioned documents by describing the special measures considered appropr iate
SECTION 3 Good production practices - fao.org
www.fao.orgSection 3 - Production, processing, storage, transport and distribution of feed and feed ingredients The production, processing, storage, transport and distribution of safe and
GOOD DOCUMENTATION AND QUALITY MANAGEMENT …
extranet.who.intSome tips on Good Documentation Practices Records should be completed at time of activity or when any action is taken Superseded documents should be retained for a ...
FR23/2017 IOSCO Report on Good Practices for the ...
www.iosco.org3 the report considers issues arising from investment fund mergers generally, as identified by IOSCO in 2004,4 and how these impact on the termination process. 1.2. Scope This report sets out proposed good practices for the voluntary terminations of open-ended and
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING …
www.who.intWorking document QAS/15.639/Rev.1 May 2016 Draft document for comment Draft document for comment 1 SUPPLEMENTARY GUIDELINES ON 2 GOOD MANUFACTURING PRACTICES FOR HEATING, 3 VENTILATION AND AIR-CONDITIONING SYSTEMS FOR 4 NON-STERILE PHARMACEUTICAL DOSAGE FORMS (May5 2016) 6 REVISED DRAFT FOR COMMENT 7 Should …